ライフサイエンスコーパス: intraabdominal infection

1 formation in an experimental animal model of intraabdominal infection.

2 or negative for acute appendicitis or other intraabdominal infection.

3 derwent relaparotomy, including two (7%) for intraabdominal infection.

4 rition because of its importance in fighting intraabdominal infections.

5 every 6 hours in the treatment of a range of intraabdominal infections.

6 adequate surgical management of complicated intraabdominal infections.

7 biotic regimens for the empiric treatment of intraabdominal infections.

8 he plethora of microorganisms encountered in intraabdominal infections.

9 s may not be applicable to all patients with intraabdominal infections.

10 as adjuncts in the management of complicated intraabdominal infections.

11 r the treatment of patients with complicated intraabdominal infections.

12 mon diagnoses were appendicitis (33%), other intraabdominal infection (29%), and abscess (25%).

13 domly assigned 518 patients with complicated intraabdominal infection and adequate source control to

14 The most common causes were intraabdominal infection and graft pancreatitis (38%), p

15 clinafloxacin in the treatment of a range of intraabdominal infections, and in patients with a broad

16 s, Infections of the Gastrointestinal Tract, Intraabdominal Infections, Bone and Joint Infections, Ur

17 s, Infections of the Gastrointestinal Tract, Intraabdominal Infections, Bone and Joint Infections, Ur

18 samples are indicated during soft tissue and intraabdominal infections, but cultures obtained through

19 HRQoL) measures in patients with complicated intraabdominal infections (cIAIs) commonly associated wi

20 tance among pathogens that cause complicated intraabdominal infections (cIAIs) supports the developme

21 Patients with intraabdominal infection enrolled in PRTs have an increa

22 nd microbiological evaluation of complicated intraabdominal infections in adults, children, and pregn

23 ventilator-associated pneumonia, complicated intraabdominal infection, or complicated urinary tract i

24 Surgical-site infection, recurrent intraabdominal infection, or death occurred in 56 of 257

25 posite of surgical-site infection, recurrent intraabdominal infection, or death within 30 days after

26 rs were treated for bloodstream, complicated intraabdominal infections, or complicated urinary tract

27 Treatment of intraabdominal infections remains a challenge, mainly be

28 The successful treatment of intraabdominal infection requires a combination of anato

29 The incidence of intraabdominal infections significantly decreased betwee

30 The incidence of intraabdominal infection was slightly higher in the SE g

31 One hundred sixty-eight adults with intraabdominal infection were treated at a single instit

32 aumatic wound infections, sepsis, burns, and intraabdominal infections were common.

33 In patients with intraabdominal infections who had undergone an adequate